Purchase Order 75N93024P00103

Award Date 3/14/24
Potential Completion Date 3/13/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Sartorius Corporation has been awarded a $18,270 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide INCUCYTE SX5 SOFTWARE/SERVICE WARRANTY under contract number 2201207. Place of performance will be in Bethesda, Maryland, with a period of performance from May 1, 2024 through April 30, 2025. As the prime contractor, Sartorius Corporation will deliver software and service...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $154,694.78 firm fixed price delivery order to Samyak Solutions, Inc. for a SARTORIUS CORPORATION BRAND INCUCYTE S3 SYSTEM. Samyak Solutions, Inc. will provide the system from their inventory as the prime contractor under their Multiple Award Schedule contract vehicle with the General Services Administration. The product will support biomedical research...
This firm-fixed-price purchase order for $15,904.85 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and biotech solutions. The contract provides for preventative maintenance services on Sartorius' proprietary IncuCyte S3 live-cell analysis systems over a period ending on December 20, 2025. As a key supplier...
The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The $16,530.00 annual service agreement is for an IncuCyte SX5 system, which supports biomedical research and drug development activities. Sartorius, a division of the parent company Sartorius Aktiengesellschaft, has a history of providing advanced...
This is a $21,394.00 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract is for annual maintenance and software upgrades for an IncuCyte live-cell imaging device. The contract has an ultimate completion date of April 30, 2026 and was not set aside for any specific...
This is a $202,196.78 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the delivery of an INCUCYTE SX5 HD/3CLR SYS PKG, which is a live-cell analysis system used to support biomedical research and development, particularly in areas such as...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases has awarded a one-year firm fixed price purchase order to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft, for $40,940.00 to provide preventative maintenance services for an IQUE3 PLUS VBR Screener. The contract has a completion date of May 14, 2025 and was awarded on May 15, 2024. No set-aside designation...
The Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute awarded a $29,089 firm fixed price purchase order to Sartorius Corporation, a division of Sartorius Aktiengesellschaft, for an annual service maintenance contract supporting the National Institute of Arthritis and Musculoskeletal and Skin Diseases Light Imaging Section IncuCyte S3. The contract has a period of performance from September 20, 2023 through September 21, 2024 and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Sartorius Corporation valued at fourteen thousand five hundred forty-four dollars and fifty-two cents ($14,544.52) to cover a Sartorius IncuCyte system under a service contract for the agency's Genetics Branch. Performance will take place from November 24, 2023 through November 23, 2024 at the agency's campus in Bethesda, Maryland. No set-aside...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.50 firm fixed price purchase order to Sartorius Corporation for preventative maintenance and service of an IncuCyte S3. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services at a location in Bethesda, Maryland through November 2024. The award utilizes a National Institutes of Health contract vehicle to procure services...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $15,310 purchase order to Sartorius Corporation for INCUCYTE S3 SW/SVC WARRANTY. Under this firm fixed price contract, Sartorius Corporation Division will provide software and service warranty for the INCUCYTE S3 system. The place of performance is Bethesda, Maryland. The one-year contract term runs from March 14, 2024 through March 13, 2025. No subcontractors or set aside designations were identified. This purchase supports the NIH's research efforts to understand, treat and prevent infectious, immunologic and allergic diseases through its intramural and extramural research programs.

Generated 12/20/23, 1:32 PM